Latest company news on US-listed stocks: earnings, guidance, deals, management changes and product announcements, linked to each ticker page.
Nasdaq
The S&P 500 Index ($SPX ) (SPY ) is down by -0.32% today, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down by -0.15%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.57%. December E-mini…
Nasdaq
Halozyme wins a Dutch court order blocking Merck's Keytruda SC in eight European markets, strengthening its position in the patent dispute.
Nasdaq
EQNR's 75.7% stock rally, rising Norwegian production, strong European gas demand and attractive valuation make a compelling case for owning the stock.
Nasdaq
Jabil expects AI revenues to surge 54% to $22.1 billion in fiscal 2027, fueling infrastructure growth and margin gains while raising execution challenges.
Nasdaq
Lemonade (NYSE: LMND) has always had an audacious idea. The insurer would rebuild insurance using artificial intelligence and behavioral economics to streamline buying policies and filing claims,…
Nasdaq
Exelon and Eversource Energy invest heavily in grid upgrades amid rising power demand. Compare their earnings, dividends, debt and growth prospects.
Nasdaq
BABA's AI cloud growth, full-stack AI strategy and resilient commerce business support holding the stock despite heavy capex and margin pressure.
Nasdaq
JBL's AI-driven growth, rising margins and strong earnings outlook bolster its investment case, but a premium to its historical valuation raises questions.
Nasdaq
Embedded insurance is transforming coverage distribution. Explore how PGR, CB, TRV, AIZ and ROOT are tapping into this fast-growing market.
Nasdaq
Fintel reports that on October 8, 2026, Roth Capital initiated coverage of New Era Energy & Digital (NASDAQGM:NUAI) with a Buy recommendation. Prior to this rating action, the stock closed at $5.53…
Nasdaq
BAYRY's Kerendia label expansion moves forward as FDA accepts an application for CKD patients without diabetes.
Nasdaq
Micron (MU) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Nasdaq
Novartis wins FDA approval for Rhapsido in symptomatic dermographism, expanding its chronic hives opportunity as pipeline setbacks raise pressure for growth.
Nasdaq
Sun Life Financial expands U.S. disability benefits with Health Navigator, aiming to improve employee care, boost cross-selling and drive long-term growth.
Nasdaq
CLS is riding AI infrastructure and 800G/1.6T networking demand, but customer concentration and competition pose risks to its growth.
Nasdaq
UNH's Q3 earnings are expected to jump 41.1% despite revenue headwinds. Can improving cost management and restructuring drive further stock gains?
Nasdaq
CLS expands its communications portfolio with 1.6T Ethernet, optical technologies and open networking for AI and cloud.
Nasdaq
Ameriprise (AMP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Nasdaq
Ametek (AME) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Nasdaq
ConocoPhillips (COP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Nasdaq
Johnson & Johnson (JNJ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Nasdaq
Bristol Myers (BMY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Nasdaq
Cadence (CDNS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Nasdaq
Pfizer (PFE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Nasdaq
WU renews its Publix deal as North American transactions fall, with the grocer's growing footprint offering ways to retain customers and spur growth.
Nasdaq
ANET's AI networking growth and expanding Ethernet opportunity fuel strong gains, but customer concentration and margin pressure cloud the upside.
Nasdaq
WAB's $700M-plus African rail deal, expanding services and robust backlog fuel growth prospects, but a premium valuation raises questions for investors.
Nasdaq
PFE's oncology growth in Q3 hinges on key drug sales, biosimilars and progress across a late-stage pipeline.
Nasdaq
The September Scramble: Find Sanctuary in These 3 Defensive Dividend StocksPepsiCo (NASDAQ:PEP) executives said third-quarter organic revenue growth accelerated while international operations…
Nasdaq
3 Fresh Stock Buybacks: These are the Ones to BuyHelen of Troy (NASDAQ:HELE) reported fiscal second-quarter 2027 results that met its sales outlook and exceeded its adjusted earnings expectations,…
Nasdaq
Does Fortinet (FTNT) have what it takes to be a top stock pick for momentum investors? Let's find out.
Nasdaq
Eni SpA (E) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Nasdaq
ANET launches an open Ethernet rack-scale portfolio for dense AI infrastructure, offering flexible scale-up and scale-out solutions.
Nasdaq
BA faces debt, production delays and poor ROIC, but new defense contracts and debt reduction offer investors a mixed outlook.
Nasdaq
XEL's Michigan asset sale aims to sharpen its core market focus, while a $60 billion investment plan and rising data center demand fuel long-term growth.
Nasdaq
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the State Street Technology Select Sector SPDR ETF (Symbol: XLK) where we…
Headlines and summaries belong to their publishers; links open the original article on the publisher's site. MetaCap does not republish third-party articles.
Market data is delayed at least 15 minutes and provided for informational purposes only. Not investment advice. Full disclaimer